The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
|Videos|December 24, 2020
Patient counseling for mesh mid-urethral sling surgery: Provide options, set expectations
Author(s)Urology Times staff
“Listen. Be emphatic. Be transparent,” Pansy Uberoi, MD, MPH, advises in this interview.
Advertisement
In this interview, Una Lee, MD, and Pansy Uberoi, MD, MPH, discuss how clinicians can improve patients’ experiences with mesh mid-urethral sling surgery. Lee and Uberoi were study authors of, “Listening to women: a qualitative analysis of experiences after complications from mesh mid-urethral sling surgery,” which was published in Urology. Lee is a urologist at Virginia Mason Medical Center, Seattle, Washington and assistant clinical professor of urology at the University of Washington, Seattle, and Uberoi is a fellow in female pelvic medicine and reconstructive surgery at Virginia Mason Medical Center.
Advertisement
Related to this article
John P. Sfakianos, MD, discusses how ctDNA can be optimally integrated into bladder cancer clinical trials.
Brian Mazzarella, MD, discusses the landscape for intermediate-risk prostate cancer and early VAPOR 2 findings on water vapor ablation.
Armine K. Smith, MD, discusses the importance of integrating sexual health into bladder cancer care, including proactive counseling, preservation strategies, and multidisciplinary support.
Positive safety and efficacy data from 4 clinical studies supported the CE marking.
Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
Eugene Cone, MD, discusses recombinant BCG for NMIBC, including ongoing clinical evaluation and its potential to address ongoing BCG supply challenges.
The safety and efficacy of vibegron are supported by data from the phase 3 COURAGE and EMPOWUR trials.
Advertisement
Advertisement
Trending on Urology Times
1
Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer
2
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
3
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
4
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
5